Navigation Links
Penn Pharma Invests In World-Class Inventory Management System
Date:1/11/2010

PHILADELPHIA, Jan. 11 /PRNewswire/ -- Global integrated pharmaceutical manufacturer, Penn Pharma, has invested more than $566,000 in a state-of-the-art inventory management system - incorporating real time bar coding control, unprecedented levels of stock accuracy and the Penn Customer Portal. This system makes Penn Pharma one of the first companies in its class in the U.S. or Europe to provide customers with an all-encompassing, remote access global product and inventory tracking service.

"As a business, we have a large worldwide market presence, particularly in the U.S. and Japan. Our investment in this new Customer Portal not only increases product visibility for customers wishing to track their order status, materials disposition and third party shipping but also further enables Penn Pharma to compete on the global stage as a standard for best practices," said Darren Hassey, chief operating officer at Penn Pharma.

The main driver behind this investment is to make the processes within Penn Pharma completely transparent for its customers so that the company becomes a client partner rather than a supplier, providing support every step of the way.

The new Penn Customer Portal is completely secure and allows customers to remotely access and track their Penn Pharma product inventory and also materials in transit to the end destination, whether it be an investigator site or customer storage facility. The Portal provides access to real time inventory information concerning excipients, Active Pharmaceutical Ingredients,(API) packaging materials and finished products/clinical packs, 24-hours-a-day, 365-days-a-year.

Innovative links with third party shipping websites also allow customers to view dispatch information via the Portal to enable tracking of materials and finished products across the supply chain.

"Our new Customer Portal system has been fully validated by an independent specialist making us the first company in Europe, if not the world, to validate this Sage 500 ERP software package to further enhance the quality of service and compliance we provide for our customers as part of our suite of integrated formulation, analytical services, clinical trials supply and clinical / commercial manufacturing solutions," said Hassey.

About Penn Pharma

Penn Pharma is a leading provider of fully integrated and cost effective pharmaceutical development and custom manufacturing services to the international healthcare industry, whose services support a fast and effective route from clinic to market. Penn Pharma provides unparalleled service offerings developed over its 30 year trading history. Penn Pharma has offices in South Wales, the UK and the U.S. www.pennpharm.com


    PR Contact:            Corporate Contact:
    Judith Eckles          Britton Jimenez
    484-684-6717           925-787-6886
    judithe@sagefrog.com   Britton.Jimenez@Pennpharm.com
    Sagefrog Marketing     Penn Pharma

SOURCE Penn Pharma

RELATED LINKS
http://www.pennpharm.com

'/>"/>

SOURCE Penn Pharma
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  American Respiratory Labs (ARL), a ... now able to perform sophisticated lung assessments in patients, homes, thanks ... Inc. Patients are no longer limited to having ... PRO ® , ARL patients like Jeanne R. of ... the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... -- In a startling report released today, National Safety Council ... comprehensive, proven plan to eliminate prescription opioid overdoses. Prescription ... are tackling the worst drug crisis in recorded U.S. history, assigned ... Kentucky , New Mexico , ... 28 failing states, three – Michigan , ...
Breaking Medicine Technology: